Eli Lilly Reports Weight Loss Results Across Menopause Stages in Obesity Drug Trial
Eli Lilly reported that its experimental obesity drug Foundayo showed consistent weight loss results across all stages of menopause. The findings are based on late-stage clinical trial data and were presented at a medical conference.
Tickers: $LLY
Topics: Eli Lilly Foundayo pharmaceuticals weight loss drugs